Jennifer Wellman is the founder of Akouos. Akouos has raised $58M in total funding. Latest round: Series A. Based in Boston, USA.
Jennifer Wellman is the SVP of regulatory at Akouos, a Boston-based biotech company focused on developing gene therapies for hearing loss. The company aims to use its ancestral AAV gene therapy platform to deliver genes to sensory cells in the inner ear. Akouos has raised a $7.5 million seed round and a $50 million Series A round. Wellman previously co-founded and served as the head of product development strategy at Spark Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library